ArticleOncogene2025

HOMER3 orchestrates SRC-YAP1 activity that promotes tumor cell growth and antagonizes anti-tumor immunotherapy in prostate cancer.

Tongyu Tong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.